SHA:600867 Revenue

Tonghua Dongbao Pharmaceutical had revenue of 707.73M CNY in the quarter ending September 30, 2024, a decrease of -2.41%. This brings the company's revenue in the last twelve months to 2.43B, down -12.24% year-over-year. In the year 2023, Tonghua Dongbao Pharmaceutical had annual revenue of 3.08B with 10.69% growth.

Revenue (ttm)

2.43B

Revenue Growth

-12.24%

P/S Ratio

6.66

Revenue / Employee

760.84K

Employees

3,196

Market Cap

14.58B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	3.08B	296.96M	10.69%
Dec 31, 2022	2.78B	-489.44M	-14.98%
Dec 31, 2021	3.27B	375.73M	12.99%
Dec 31, 2020	2.89B	115.02M	4.14%
Dec 31, 2019	2.78B	84.22M	3.13%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	27.98B
Shenzhen Mindray Bio-Medical Electronics	37.11B
WuXi AppTec	37.92B
Aier Eye Hospital Group	20.62B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Yunnan Baiyao Group Co.,Ltd	39.34B
Shanghai United Imaging Healthcare	10.30B
Sichuan Biokin Pharmaceutical	5.82B

Revenue Rankings